DK132174C - Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner - Google Patents

Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner

Info

Publication number
DK132174C
DK132174C DK513771A DK513771A DK132174C DK 132174 C DK132174 C DK 132174C DK 513771 A DK513771 A DK 513771A DK 513771 A DK513771 A DK 513771A DK 132174 C DK132174 C DK 132174C
Authority
DK
Denmark
Prior art keywords
benzylpyrimidines
diamino
preparation
analogical procedure
analogical
Prior art date
Application number
DK513771A
Other languages
Danish (da)
English (en)
Other versions
DK132174B (da
Inventor
B Roth
A Stuart
T Paterson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK132174B publication Critical patent/DK132174B/da
Application granted granted Critical
Publication of DK132174C publication Critical patent/DK132174C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK513771A 1970-10-22 1971-10-21 Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner DK132174C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (US08067413-20111129-C00011.png) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (2)

Publication Number Publication Date
DK132174B DK132174B (da) 1975-11-03
DK132174C true DK132174C (da) 1976-03-29

Family

ID=27255400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK513771A DK132174C (da) 1970-10-22 1971-10-21 Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner

Country Status (20)

Country Link
JP (2) JPS5536662B1 (US08067413-20111129-C00011.png)
AR (3) AR192588A1 (US08067413-20111129-C00011.png)
AT (1) AT319948B (US08067413-20111129-C00011.png)
BE (1) BE774281A (US08067413-20111129-C00011.png)
BG (4) BG20364A3 (US08067413-20111129-C00011.png)
CA (1) CA967158A (US08067413-20111129-C00011.png)
CH (3) CH568301A5 (US08067413-20111129-C00011.png)
DD (1) DD100877A5 (US08067413-20111129-C00011.png)
DK (1) DK132174C (US08067413-20111129-C00011.png)
ES (1) ES396219A1 (US08067413-20111129-C00011.png)
FI (1) FI56175C (US08067413-20111129-C00011.png)
FR (1) FR2111769B1 (US08067413-20111129-C00011.png)
GB (1) GB1375162A (US08067413-20111129-C00011.png)
IE (1) IE37452B1 (US08067413-20111129-C00011.png)
IL (2) IL37984A (US08067413-20111129-C00011.png)
LU (1) LU64129A1 (US08067413-20111129-C00011.png)
MC (1) MC894A1 (US08067413-20111129-C00011.png)
NL (1) NL175178C (US08067413-20111129-C00011.png)
SE (2) SE384505B (US08067413-20111129-C00011.png)
ZM (1) ZM14971A1 (US08067413-20111129-C00011.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
ZW9979A1 (en) * 1978-05-24 1980-12-24 Wellcome Found Benzylpyrimidine compositions
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路
AU2005226359B2 (en) 2004-03-26 2011-02-03 Astrazeneca Aktiebolag 9-substituted 8-oxoadenine compound
JP2009542645A (ja) 2006-07-05 2009-12-03 アストラゼネカ・アクチエボラーグ Tlr7のモジュレーターとして作用する8−オキソアデニン誘導体
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
EP2139894B1 (en) 2007-03-19 2011-10-26 AstraZeneca AB 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
SI2132209T1 (sl) 2007-03-19 2014-05-30 Astrazeneca Ab Spojine 9-substituiranega-8-okso-adenina, kot modulatorji Toll-like receptorja (TLR7)
WO2008114819A1 (ja) 2007-03-20 2008-09-25 Dainippon Sumitomo Pharma Co., Ltd. 新規アデニン化合物
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
BRPI1010937A2 (pt) 2009-05-21 2019-09-24 Astrazeneca Ab composto, uso de um composto, e, método para tratar câncer
WO2012080728A1 (en) 2010-12-16 2012-06-21 Astrazeneca Ab Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
EP2651943B1 (en) 2010-12-17 2017-03-22 Sumitomo Dainippon Pharma Co., Ltd. Purine derivatives
BR112014029261A2 (pt) 2012-05-18 2017-06-27 Astrazeneca Ab compostos de ácido carboxílico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (US08067413-20111129-C00011.png) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Also Published As

Publication number Publication date
FI56175C (fi) 1979-12-10
AT319948B (de) 1975-01-10
CH582681A5 (US08067413-20111129-C00011.png) 1976-12-15
IE37452L (en) 1972-04-22
JPS53135991A (en) 1978-11-28
BG21406A3 (bg) 1976-05-20
IL37984A (en) 1976-03-31
CH568302A5 (US08067413-20111129-C00011.png) 1975-10-31
SE409705B (sv) 1979-09-03
MC894A1 (fr) 1972-06-22
DD100877A5 (US08067413-20111129-C00011.png) 1973-10-12
IL45422A (en) 1976-03-31
BE774281A (fr) 1972-04-21
AR192802A1 (es) 1973-03-14
BG20364A3 (bg) 1975-11-05
FR2111769B1 (US08067413-20111129-C00011.png) 1974-10-18
FR2111769A1 (US08067413-20111129-C00011.png) 1972-06-09
IL37984A0 (en) 1971-12-29
ES396219A1 (es) 1975-09-16
DK132174B (da) 1975-11-03
SE384505B (sv) 1976-05-10
BG20365A3 (bg) 1975-11-05
ZM14971A1 (en) 1972-07-21
GB1375162A (US08067413-20111129-C00011.png) 1974-11-27
NL175178B (nl) 1984-05-01
LU64129A1 (US08067413-20111129-C00011.png) 1972-06-28
NL7114494A (US08067413-20111129-C00011.png) 1972-04-25
AR192803A1 (es) 1973-03-14
CH568301A5 (US08067413-20111129-C00011.png) 1975-10-31
BG20797A3 (bg) 1975-12-20
FI56175B (fi) 1979-08-31
IE37452B1 (en) 1977-08-03
AR192588A1 (es) 1973-02-28
CA967158A (en) 1975-05-06
JPS5536662B1 (US08067413-20111129-C00011.png) 1980-09-22
NL175178C (nl) 1984-10-01

Similar Documents

Publication Publication Date Title
DK143799C (da) Fremgangsmaade til fremstilling af n-1,1,1-trisubstituerede methylazoler
DK132174C (da) Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK136612C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-4-pregnen-21-syrederivater
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
DK138016C (da) Analogifremgangsmaade til fremstilling af 1-aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-2-oner
DK133468C (da) Analogifremgangsmade til fremstilling af 1-benzyl-3-amino-pyrazoloner-(5).
DK132703C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK135131C (da) Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner
DK132760C (da) Analogifremgangsmade til fremstilling af 6,21-dihalogen-16alfa,17alfa-dihydroxy-pregna-4,6-dien-3,20-dioner
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK140551B (da) Fremgangsmaade til fremstilling af diazabicycloalkanderivater
DK132121C (da) Fremgangsmade til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion
DK132949B (da) Analogifremgangsmade til fremstilling af 1,6-di-o-alkylsulfonyl-2, 3-4,5-dianhydro-iditol-derivater
DK132440C (da) Analogifremgangsmade til fremstilling af 11-oxygenerede 2-chlor-6alfa,9alfa-difluor-16alfa-methyl-3,20,21-trioxo-1,4-pregnadiener eller 21-aldehydhydrater, -estere eller -acetaler deraf
DK139577C (da) Fremgangsmaade til fremstilling af des-phenylalaninb1-insulin
DK137678C (da) Analogifremgangsmaade til fremstilling af 4-alkylamino-pyrimido-(4,5,b)-quinoxalin-5,10-dioxider
DK140253C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydroindan-1,5-dioner
DK131787C (da) Analogifremgangsmade til fremstilling af 2-klor-delta1,4-pregnadien-3,20-dioner
DK137123C (da) Fremgangsmaade til fremstilling af exo- og endoethyl-1,1a,2,6b-tetrahydrocycloprop(b)indol-1-carboxylsyrer
DK138543C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepinderivater
DK132660C (da) Analogifremgangsmade til fremstilling af 1,5-benzodiazepinderivater
SE389112B (sv) Analogiforfarande for framstellning av 2-amino-dihydro-1,5-benzodiazepinoner

Legal Events

Date Code Title Description
PBP Patent lapsed